Abstract
No public abstract is available from the verified source records.
Guang-Yi Sun, Si-Ye Chen, Yong-Wen Song, Yue-Ping Liu, Ning-Ning Lu, Shu-Nan Qi, Hao Jing, Yi-Rui Zhai, Wen-Wen Zhang, Zhuan-Bo Yang, Xu-Ran Zhao, Yu-Chun Song, Dan-Qiong Wang, Zi-Han Qiu, Chao-Nan Zhang, Shi-Jie Yang, Jing-Ru Zhu, Jia-Rong Liu, Xu-Wen Shen, Chen Hu, Ye-Xiong Li, Shu-Lian Wang
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
10.1016/s0140-6736(14)60488-8 · 2014
Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis
10.1136/bmj-2023-079089 · 2024
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial
10.1016/s1470-2045(18)30813-1 · 2019
Postmastectomy radiation therapy: an ASTRO-ASCO-SSO clinical practice guideline
10.1200/jco-25-01747 · 2025
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer
10.1016/s1470-2045(21)00539-8 · 2022
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
10.1016/s1470-2045(13)70386-3 · 2013
Long-term results of hypofractionated radiation therapy for breast cancer
10.1056/nejmoa0906260 · 2010
Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials
10.1016/j.radonc.2017.10.033 · 2018
Late-term effects of hypofractionated chest wall and regional nodal radiotherapy with two-dimensional technique in patients with breast cancer
10.3857/roj.2020.00129 · 2020
Effect of elective internal mammary node irradiation on disease-free survival in women with node-positive breast cancer: a randomized phase 3 clinical trial
10.1001/jamaoncol.2021.6036 · 2022
Regional nodal irradiation in early-stage breast cancer
10.1056/nejmoa1415340 · 2015
Side effects 15 years after lymph node irradiation in breast cancer: randomized EORTC trial 22922/10925
10.1093/jnci/djab113 · 2021
Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial
10.1016/j.radonc.2022.03.008 · 2022
Pulmonary function and lung fibrosis up to 12 years after breast cancer radiotherapy
10.1016/j.ijrobp.2023.10.026 · 2024
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial
10.1016/s0140-6736(23)00619-0 · 2023
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
10.1016/s0140-6736(20)30932-6 · 2020
Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer
10.1093/jnci/94.15.1143 · 2002
Spontaneous rib fractures after breast cancer treatment based on bone scans: comparison of conventional versus hypofractionated radiotherapy
10.1016/j.clbc.2020.07.009 · 2021
Effects of tumor–rib distance and dose-dependent rib volume on radiation-induced rib fractures in patients with breast cancer
10.3390/jpm12020240 · 2022
Toxicity evaluation of dose-escalation in hypofractionated regional nodal irradiation for breast cancer: a retrospective study
10.1016/j.ijrobp.2024.04.014 · 2024
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial
10.1016/s0140-6736(25)02597-8 · 2026
5027 DBCG Skagen trial 1: phase III randomised trial of hypo- vs standard fractionated loco-regional radiotherapy in node-positive breast cancer patients
10.1016/s0167-8140(25)04203-3 · 2025
Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study
10.1016/j.radonc.2025.110915 · 2025
Intensity-modulated radiation therapy for early-stage breast cancer: a systematic review and meta-analysis
2024
A randomized trial of hypofractionated post-mastectomy radiation therapy (PMRT) in women with breast reconstruction (RT CHARM, Alliance A221505)
10.1016/j.ijrobp.2024.07.002 · 2024
Hypofractionated vs conventionally fractionated postmastectomy radiation after implant-based reconstruction: a randomized clinical trial
10.1001/jamaoncol.2024.2652 · 2024
Comparison of hypofractionation and conventional fractionation in postmastectomy radiotherapy after immediate breast reconstruction: a systematic review and meta-analysis of complications
10.1016/j.ejca.2025.115669 · 2025
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial
10.1200/jco.22.01565 · 2023
No additional external references are available.